MAIN MENU

BACK

BACK

  • Home

  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
Explore PAREXEL
  • JourneyGO
  • SolutionsGO
  • ExperienceGO
  • Outsourcing ModelsGO
  • Planning
  • Phase I
  • Phase IIa
  • Phase II-III
  • Phase IIIb-IV
  • Post Launch
  • Clinical Research
    • Early Phase Services
      • Dedicated Therapeutic Expertise
        • Early Phase and Late Phase integrated study management
      • Patient Populations
      • Strategic Locations
        • Berlin
          • Virtual Tour
        • London
          • Virtual Tour
        • Baltimore
          • Facility
          • Virtual Tour
        • Los Angeles
          • Virtual Tour
      • Phase 1, First in Human
        • Ethnobridging for Accelerated Global Drug Development
      • Phase IIa, Proof of Concept
      • Early Product Development
      • Ethnobridging
      • Clinical PK/PD and Pharmacometrics Services
        • Case Study: Safety/Pharmacovigilance #1
        • Case Study: Safety/Pharmacovigilance #2
      • Bioanalytical and Biomarkers
      • Bioequivalence Studies
      • Volunteer to Participate
    • Phase II-III Services
      • Phase III
        • Case Study: Chronic Renal Failure
        • Case Study: Expanded Access Program
        • Case Study: Accelerating development in global COPD trials
      • Medical Writing and Submission
      • Feasibility and Enrollment
        • Patient Recruitment
          • Case Study: Pediatric Migraine Patient Recruitment
        • Country and Site Selection
        • Alliance Site Strategy
        • Protocol Optimization
    • Phase IIIb-IV
    • ForeSite™ Clinical Trial Methodology
      • Study Design
      • Study Start-Up
      • Study Execution
    • Global Data Operations
      • Clinical Data Management
      • Biostatistics Services
      • Clinical MetaData Repository (MDR)
    • Medical Writing Solutions
    • Quantitative Clinical Development Services
    • Clinical Trial Supplies & Logistics
      • Global Reach
      • Clinical Trial Supplies
      • Ancillary Supplies
      • Laboratory Logistics and Biological Sample Lifecycle Management Services
      • Randomization and Trial Supply Management
      • Cold Chain Logistics
      • Clinical Trial Supply Chain - Active Tracking
    • Customer Care Services
    • Genomic Medicine Services
    • Clinical Adjudication Services
  • Informatics
    • Regulatory and Clinical Technology
      • Regulatory Information Management
        • LIQUENT InSight®
        • Regulatory Cloud
        • Regulatory Outsourcing Services
      • Data-Driven Monitoring
      • Clinical Trial Management System (CTMS)
        • IMPACT® CTMS Software
      • Electronic Data Capture
        • DataLabs® EDC
      • MyTrials® Analytics
    • Patient Technology
      • Randomization and Trial Supply Management
        • Clinical Trial Supplies & Logistics
        • Clinical Trial Supply Chain - Active Tracking
        • ClinPhone RTSM Mobile App
      • Medical Imaging
        • Therapeutic Expertise
          • Oncology Imaging Expertise
            • Criteria Experience
              • 1996 NCI-WG CLL
              • IWCLL 2008
                • Key Topics: IWCLL 2008
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • B symptoms
                  • Blood Counts
                  • Bone Marrow
                  • Transformation
                  • Role of Imaging in CLL Clinical Trials
                  • Clinical Data Assessments
              • 1999 IWG-NHL
              • 2007 IWG-NHL
                • Key Topics: 2007 IWG-NHL Assessment Criteria
                  • Definitions
                  • Usable Criteria to Evaluate
                  • Target Sites of Disease
                  • Non-Target Sites of Disease
                  • Organomegaly
                  • New Lesions
                  • Bone Marrow
                  • Other Laboratory Values and Symptoms
                  • Incorporation of FDG-PET
                  • Defining Normal, Abnormal and Measurable
                  • Problem with CRu
              • RECIST
          • Neurology Imaging Expertise
          • Musculoskeletal (MSK) Imaging Expertise
          • Women's Health Imaging Expertise
          • Dermatology Imaging Expertise
          • Gastroenterology Imaging Expertise
          • Ophthalmology Imaging Expertise
          • Volumetric Imaging Expertise
          • Cardiovascular Imaging Expertise
        • Imaging Services
        • Scientific Advisors
        • Consultation
        • Advanced Medical Imaging
          • Cloud-Based Solutions for Sites
      • Patient Sensors
      • Electronic Clinical Outcome Assessments (eCOA)
        • ePRO (electronic Patient Reported Outcomes)
        • Clinical Outcome Assessments Consulting
    • Clinical Trial Supplies & Logistics
    • Perceptive® Cloud
    • Asset Transfer Services
    • PAREXEL's Education Services
      • IMPACT® CTMS Training
      • LIQUENT InSight® Training
        • Courses & Registration
          • LIQUENT InSight® for Submission Management
            • LIQUENT InSight®Submission Planning and Tracking
          • LIQUENT SmartDesk™
            • Automating the Publishing Process with LIQUENT SmartDesk™ for PDF
          • LIQUENT InSight for Viewing
            • Reviewing Submissions with LIQUENT InSight® for Viewing
        • Training Resources
      • DataLabs® EDC Training
      • Perceptive MyTrials® Training
      • Data-Driven Monitoring Training
      • Certification Programs
      • Other Training Services
    • Customer Care Services
  • Consulting
    • Integrated Product Development
      • A Biosimilar Milestone with Implications
    • Regulatory Compliance & Risk Management
      • Q&A about GCP
        • Quality By Design Putting Theory Into Practice
      • Strategic Compliance: Data Integrity
      • FDA 483s: Your Questions Answered
      • Important Reminder About PET (Positron Emitting Topography) FDA Regulations
      • Quality By Design Putting Theory Into Practice
    • Regulatory Outsourcing Services
      • eCTD
    • Clinical Trial Regulatory Services
    • Regulatory Information Management & IDMP Solutions
      • IDMP Readiness Assessment
      • IDMP Task Force Updates
        • November 2015 Task Force Meeting
    • Market Access Consulting
  • Access
    • Real World Evidence
      • Late Phase Clinical Operations
        • Late Phase Interventional Trials
        • Observational Research
        • Epidemiology
        • Expanded Access Programs
        • Clinical Outcome Assessment (COA)
          • Case Study: Health Economics
          • Outcomes Research
      • Real World Data Services
    • Drug Safety Services
      • Risk Management / REMS
    • Market Access Consulting
      • Commercial Decision Pathways
      • Evidence Generation
        • Evidence Review and Meta-Analysis
          • Evidence Review Options
          • Evidence Review Resources
        • Health Economic Modeling
        • Global and AMCP Value Dossiers
        • Manuscripts and Posters
        • Data Analytics
        • Strategic Communications
      • Access Realization
        • Pricing, Reimbursement and Market Access Expertise
        • List of Services: Pricing, Reimbursement and Market Access
    • Medical Communications
      • Communication Strategy
      • Publications Planning and Scientific Content
      • Expert Identification and Engagement
      • Global Study Engagement
      • Branding and Creative Strategy
      • Digital Media and Video Solutions
      • Live and Virtual Events
      • Payer Communication
      • Editorial and Production
    • Outsourced Field-Based Medical Teams
  • Therapeutic Expertise
    • Oncology
    • Cardiovascular & Metabolic Diseases
    • Central Nervous System (CNS) Disorders
    • Infectious Disease
    • Respiratory Capabilities
    • Rheumatology & Immunology Capabilities
    • Rare Diseases
  • Industry Expertise
    • Pharmaceuticals
      • Biosimilar Consulting
    • Medical Devices
    • Biologics
    • Biosimilars
      • Biosimilar Video
  • Regulatory Expertise
  • Market Access Expertise
  • Global Presence
    • North America
    • South America
    • Europe
    • Asia
    • Middle East & Africa
    • Emerging Markets
  • Strategic Partnerships
  • ExecuPharm Functional Service Solutions
  • PAREXEL® BioPharm Unit
  • About
  • News & Events
  • Careers
  • Countries
  • Contact Us
  • Volunteer
  • PAREXEL Academy
  • Partners
  • Client Login
  • Journey
    • Planning
    • Phase I
    • Phase IIa
    • Phase II-III
    • Phase IIIb-IV
    • Post Launch
  • Solutions
    • Clinical Research
      • Early Phase Services
      • Phase II-III Services
      • Phase IIIb-IV
      • ForeSite™ Clinical Trial Methodology
      • Global Data Operations
      • Medical Writing Solutions
      • Quantitative Clinical Development Services
      • Clinical Trial Supplies & Logistics
      • Customer Care Services
      • Genomic Medicine Services
      • Clinical Adjudication Services
    • Informatics
      • Regulatory and Clinical Technology
      • Patient Technology
      • Clinical Trial Supplies & Logistics
      • Perceptive® Cloud
      • Asset Transfer Services
      • PAREXEL's Education Services
      • Customer Care Services
    • Consulting
      • Integrated Product Development
      • Regulatory Compliance & Risk Management
      • Regulatory Outsourcing Services
      • Clinical Trial Regulatory Services
      • Regulatory Information Management & IDMP Solutions
      • Market Access Consulting
    • Access
      • Real World Evidence
      • Drug Safety Services
      • Market Access Consulting
      • Medical Communications
      • Outsourced Field-Based Medical Teams
  • Experience
    • Therapeutic Expertise
      • Oncology
      • Cardiovascular & Metabolic Diseases
      • Central Nervous System (CNS) Disorders
      • Infectious Disease
      • Respiratory Capabilities
      • Rheumatology & Immunology Capabilities
      • Rare Diseases
    • Industry Expertise
      • Pharmaceuticals
      • Medical Devices
      • Biologics
      • Biosimilars
    • Regulatory Expertise
    • Market Access Expertise
    • Global Presence
      • North America
      • South America
      • Europe
      • Asia
      • Middle East & Africa
      • Emerging Markets
  • Outsourcing Models
    • Strategic Partnerships
    • ExecuPharm Functional Service Solutions
    • PAREXEL® BioPharm Unit
  • Company
    • Management Team
      • Jamie Macdonald
      • Roland Andersson, Ph.D.
      • Michael Crowley
      • Xavier Flinois
      • Michele Fournier
      • David J. Godwin
      • Simon Harford
      • Sy Pretorius, M.D.
      • Gadi Saarony
    • News & Events
      • Press Releases
      • Events
      • Webinars
      • 12th Annual Partnerships in Clinical Trials Congress
      • Archived PAREXEL in the News
    • Find an Office
    • Careers
      • Careers at PAREXEL®
      • CEO Message
      • Find Your Path - Opportunities
      • University Graduates – Opportunities for students
    • Volunteer
      • About Us
      • Locations Worldwide
      • About Clinical Trials
      • Why Participate?
      • FAQs
      • Glossary
    • Sustainability
      • Consumption Trend Analysis
    • Code of Conduct
    • eClinical Innovation
    • Purchasing
      • Purchase Order Terms and Conditions
      • Bedingungen für den Kaufauftrag
      • Vigente desde el
      • PO Terms - Japanese
      • PO Terms - Chinese 'S'
      • PO Terms - Chinese 'T'
      • Ordem de Compra Termos e Condições
    • Contact Us
      • Thank You
    • Partners
      • Service Partners
      • Training Partners
      • Technology Partners
      • Referral Partners
      • Accredited Partner Program
    • PAREXEL Reports U.K. Gender Pay Data
  • Perceptive®
  • User Group Meeting
    • IMPACT CTMS User Group Meeting Details and Agendas
    • IMPACT CTMS User Group Meeting Justification Letter
    • Meeting Registration and Hotel Details
    • Benefits for attending the IMPACT CTMS User Group Meeting
    • Registration Rates
    • Hotel Rates
  • Horizons
    • About
    • Locations
    • FAQs
    • Agenda
  • RWE Symposia
    • About
    • Locations
    • FAQs
    • Agenda
  • Graduate | PAREXEL
    • Culture at PAREXEL
    • Former Trainees at PAREXEL
      • Career Trainee Meghan
      • Career Trainee Sam
    • Great Place to Work
    • PAREXEL Overview
    • Clinical Trainee Program Belgium
    • Clinical Trainee Program Japan
    • Graduate Scheme India
    • Clinical Research Awards
    • Graduate Scheme UK
  • parexel-insights
    • When It Comes to CTMS One Size Does Not Fit All
    • This Disease Will Not Win the Fight
    • Designing Trials Payers Can Trust
    • Utilizing Secondary Healthcare Data Assets
    • RIM & IDMP Synergies
    • Clarifying the Criteria that Better Capture Antitumor Activity of Immune Therapeutics
    • 'Now is the time to include Japan' says PAREXEL
    • High Performance Workplace Practices That Attract and Retain Millennials
    • Clinical Trial Feasibility & Patient Enrollment: Differentiation Through Innovation
    • Developing Drugs in the New Era of Personalized Medicines
    • Interview with PAREXEL’s Aida Sabo, About Challenges & Successes in Diversity & Inclusion
    • Imaging Endpoint Selection For Biosimilar Development
    • CONSIDERATIONS IN BIOSIMILARS DEVELOPMENT– A US FDA PERSPECTIVE
    • Protocol Optimization
    • New Approaches to Data Management in Clinical Trials
    • 30 Years Later: Lessons from Living in a Pandemic
    • Why RTSM & IRT stand for Speed, Simplicity & Service
    • PAREXEL’s Training Approach and the Importance of Training a Global Workforce
    • Involved & Engaged: The Last Mile of Business Performance
    • Adaptive Trials: Complex But Advantageous
    • Grateful for Advancements in Medicine
    • The Human Touch: Aligning Reward Systems with Company Strategy and Meaningful Work
    • Orphan Drug Pricing in Europe
    • Generating Evidence to Drive Patient Access
    • Life is Short and Love is Eternal
    • The Complete Journey: Improving Clinical Trials Using Modern Technology
    • A People Strategy Attracts the Best Talent
    • Clinical Development of Next Generation Biologics
    • Best Practices to Improve the IRT Site User Experience
    • If You Never Stop Learning, You Can Never Stop Earning
    • PAREXEL's Connected Journey™ of Data-Driven Services
    • Focused on the Finish Line
    • Using Analytics to Optimize The Clinical Development Process
    • Accelerated Pathways: Global Opportunities & Challenges for Innovators
    • Immuno-Oncology: Past, Present and Future
    • How do eClincal solutions Increase Clinical Trial Efficiency?
    • Successfully Integrating Electronic Health Record and Electronic Data Collection Data
    • How to Maximize Potential and Sidestep Pitfalls of MAPs
    • World Cancer Day: Reflecting on Progress and Hope for Patients
    • Progress in Pursuit of a Cure - World AIDS Day 2017
    • How Performance Reviews Support High-Performance Talent
    • How Protocol Optimization Improves Clinical Trial Outcomes
    • Optimizing the clinical development process with Social, Mobile, Analytics, and Cloud (SMAC)
    • Overcoming Data Capture and Management Challenges
    • Running with a Purpose
    • Three Keys To Mitigating Risk In Adaptive Trials
    • Diversity and Inclusion: This Is How the Best Global Companies Learn, Plan, and Measure Success
    • Dream or Reality- Improving Patient Safety & Reducing Costs?
    • Attitude is Everything
    • Key Considerations In Biologics Clinical Development
    • Dr. Sy Pretorius, Chief Scientific Officer Talks About Adaptive Design Trials
    • Your clinical trial supply may be at risk – Brexit and the impact on IMP distribution
    • Innovation in the Pharmaceutical Industry: A Change Toward Personalized Medicine
    • Recorded Webinar: Getting to Approval Faster Through Technology Innovation
    • Data Management Roles, Process and Technologies in Risk Based Study Execution
    • You’re Hot Then You’re Cold -Temperature Management & RTSM Integration
    • Precision Medicine’s Next Hurdle: Quality Management of Human Samples
    • Navigating Regulatory Submissions
    • Dragons - the Guardians of Disease
    • Shogo Nakamori Discusses Joint Program for Clinical Research
    • Genomic Medicine, Data Modeling and Clinical Trials
    • Recognizing Uncle David
    • Demonstrating Value and Managing Risk Throughout Development
    • Shogo Nakamori Discusses Trends in Drug Development in Japan
    • Increasing Study Predictability
    • On Demand Webinar - The Power of Foresight: Improving Drug Development Performance through Optimized Protocol Design
    • Want Your Business to Thrive? Focus on Developing Your People
    • Anything is Possible
    • PAREXEL Celebrates International Women's Day 2018
    • Get Into Pole Position with Modern IRT Services
    • Drew Garty Discusses Data Driven Monitoring
    • Rooting for Team Jessie
    • Beyond Diversity: What Happens When You Define a Culture of Inclusion
    • Quantitative Modeling For Clinical Trials
    • How to Know You’re Keeping Your (Clinical Trial Supplies) Cool
    • The Next Generation of Talent Management: Opportunities For Diversity
    • Contracting - A Key Component Of A Strong Vendor Relationship
    • Albert Siu, PhD, Explains How PAREXEL Academy Benefits Clients
    • Three Skills Developers Will Need to Thrive in the New Era of Genomic Medicine
    • Aligning on Patient Outcomes – How Market Dynamics Can Facilitate RWD (Real World Data) Solutions in Research
    • Accelerated Pathways and Stock Prices
    • Improving Site Experience with Risk-Based Monitoring
    • Roland Andersson, SVP, Discusses Investing Trends and Emerging Biopharmaceutical Companies
    • Shogo Nakamori Discusses Japan & Multi-national Trials
    • What You Need To Know About Biosimilars Development
    • Wearables Shaping the Future of Clinical Trials
    • Training Compliance is an Increasingly Complex Journey
    • Why Strategy is Not Enough: Building the Bridge From Strategy to Results Requires Organizational Excellence
    • Mergers & Acquisitions: Where’s the Real Finish Line?
    • The Collaborative Advantage of Biopharma Companies and Global Service Providers
    • 3 Principles for a Sound Clinical and Regulatory Document Strategy for Small Biopharmaceuticals
    • Navigating Regulatory Complexities Of Biosimilar Development
    • Josh Schultz, Corp. VP Talks About PAREXEL Access
    • Something Good Always Comes From Something Bad
    • "Yes, I Can!"
    • Working Towards a Glimpse of a Cure
    • World Cancer Day: Breakthroughs and Challenges for Precision Medicine
    • Surveillance or Surgery?
    • Clinical Trial Support Query - Who Ya Gonna Call?
    • Leveraging the Cloud to Accelerate Time to Treatment
    • A Biosimilar Milestone with Implications
    • The Clinical, Regulatory and Commercial Implications of Rapid Approval
    • Biosimilar mAbs – a unique and distinct market (for the time being…?)
    • Accelerated Pathways & Commercial Consequences Forum & Findings
    • WHAT CAN WE LEARN FROM IMMUNO-ONCOLOGY CLINICAL TRIALS?
    • When the Doctor Becomes the Patient
    • Albert Liou Discusses the Drug Development Landscape in Korea
    • Effective Late Stage Pathways For Biosimilar Products
    • How to Simplify Site Tasks and Help Ensure Dispensing Accuracy
    • Medical Writing for Submission to Asia-Pacific Regulatory Authorities
    • The Life of a Human Biological Sample: A Look Inside and How to Maintain Its Integrity
    • The Impact of the Digital Human Resources Organization on People - Part 1
    • The Evolution of Drug Development & Market Access via Connected Data-driven Solutions
    • The Emerging Role of Wearable Devices For Real-World Data Collection
    • Active Tracking Is Out To Reduce Sites’ Workload
    • Ubavka DeNoble Talks About PAREXEL's BioPharm Unit
    • The Journey Continues – I Got This
    • So, My Fitbit is Clinical Trial Grade Right?
    • Latin America’s Role in Clinical Studies
    • Trends in Translational Development
    • Effective use of Value to Achieve Optimal Market Access
    • Three Ways to Mitigate the Risk of Late-stage Failure in CNS Drug Development
    • HOW TO EFFECTIVELY DEVELOP CLINICAL DOCUMENTS IN THE EU/US AND CHINA NDA DOSSIER
    • The Art and Science of Productive FDA Meetings
    • Driving the Digital Transformation of the Industry
    • Regulatory Strategy In Emerging Markets
    • Exploring Our Partnership with CHA Medical Group
    • PAREXEL Introduces Jamie Macdonald as Chief Executive Officer
    • Understanding different stakeholder requirements throughout commercialization
    • Development considerations: Comparing major markets including US, EU, Japan and China
    • Risk and Common Mistakes in Import and Export Documentation for Clinical Trials
    • Operational Aspects Of Independent Reviews for Immune-Oncology Clinical Endpoints
    • PAREXEL Academy Introduces New Collaboration to Develop Japan’s Biopharmaceutical Workforce of the Future
    • The Evolution of Randomization and Trial Supply Management Services
  • agile-IRT
    • Agile IRT
    • Reduced Timelines
    • Simpler Processes
    • Expert Services
    • Contact
  • test
    • Graduate | PAREXEL
  • Menu
Home > Solutions > Access > Outsourced Field-Based Medical...

OFFERED BY

  • Access

Incorporates

Access Solutions

  • Real World Evidence
  • Drug Safety Services
  • Market Access Consulting
  • Medical Communications
  • Outsourced Field-Based Medical Teams

Outsourced Field-Based Medical Teams

Customized and flexible medical affairs solutions

Following PAREXEL’s acquisition of The Medical Affairs CompanyTM (TMAC), we are now able to provide our clients field-based medical teams and customized medical liaison programs to support and enhance the exchange of scientific information between our clients and the medical community.

We provide completely flexible field-based medical affairs solutions and a variety of engagement models to meet our client’s individual resource, timing and budget challenges. Expertise available includes Medical Science Liaisons (MSLs), Clinical Trial Liaisons (CTLs), Clinical Specialists (CSs), Managed Care Liaisons and Management and Training personnel. We pride ourselves on the fact that our high quality teams are relied upon as an integral part of the client’s organization, often just the same as their internal headcount. 

 MEDICAL SCIENCE LIAISONS (MSLs)

  • Medical Science Liaisons are doctoral level and advanced degreed healthcare professionals acting as regional extensions of your medical affairs departments. They engage with a wide range of HCP stakeholder audiences answering their clinical questions about your drugs/devices and the diseases those treat.

     

 CLINICAL TRIAL LIAISONS (CTLs)

  • Qualified to doctoral level and advanced degreed healthcare professionals, our Clinical Trial Liaisons support your clinical trial needs. Each CTL is focused on providing awareness of a clinical trial, ultimately resulting in increased patient enrollment for your trial. They possess strong backgrounds in clinical research and clearly understand the clinical development process.

CLINICAL SPECIALISTS (CSs)

  • Each Clinical Specialist on our team are credentialed professionals that work on behalf of you, providing regional and community level HCPs with educational support, including in-services, technical training and clinical reinforcement messaging. Our CSs are regional and local extensions of our clients’ medical affairs departments and closely collaborate with their commercial teams.

 MANAGED OUTCOMES LIAISONS (MOLs)

  • Managed Outcomes Liaisons are doctoral level healthcare professionals with expertise in public health and/or outcomes. Each MOL aims to convey the clinical utility of our clients’ drugs and support the value proposition as to why these drugs should be utilized by payers and their members.

 CLINICAL NURSE EDUCATORS (CNEs)

  • Clinical Nurse Educators are deployed to address a specific gap for a product where utilization, adherence, or uptake is limited or challenging. Through peer-to-peer discussions with target HCPs and Nurses, CNEs can provide hands on training for products, devices and education on the disease management tools used to diagnose and treat chronic conditions.

Key Offerings
Key Materials

Key Offerings

Key Materials

SHOW MORE
SHOW MORE

Make Outsourced Field-Based Medical Teams part of your solution

The Medical Affairs Company (TMAC), now part of PAREXEL® International, provides clients an impressive complement of both strategic and tactical medical affairs solutions. Our services include the provision of contract and direct placement of field-based medical teams, medical information and medical affairs consulting, all designed to address company resource, timing and budget challenges.

Access

Products and Services

At PAREXEL, we understand that the rigors of clinical development are matched only by the demands of stakeholders for evidence demonstrating product safety, effectiveness, and value.

  • Real World Evidence
  • Drug Safety Services
  • Market Access Consulting
  • Medical Communications
  • Outsourced Field-Based Medical Teams

*PAREXEL ACQUIRES TMAC (THE MEDICAL AFFAIRS COMPANY)

White Male Business Hexagons Blue_Low Res_shutterstock_304134272.jpg  

February 1, 2017 – PAREXEL announced that the Company has entered into a definitive agreement to acquire The Medical Affairs Company, LLC (“TMAC”), a leading provider of outsourced medical affairs services to the pharmaceutical, biotechnology, and medical device industries. See full press release >

View

Overview Brochure

 TMACbrochure thumb.PNG

Download Now
RELATED CONTENT

Linkedin Updates

View Profile
    Warning: Invalid argument supplied for foreach() in /home/saltwater/www/www.parexel.com/site/themes/parexel-responsive/elements/footer.php on line 27

CAREERS AT PAREXEL®

If you are inspired to make a difference
in the world, we can help you make it possible.

Search job openings worldwide

PAREXEL International Corp.
+1 781 487 9900
195 West Street
Waltham, MA 02451 

  • ABOUT PAREXEL®
  • NEWS & EVENTS
  • VOLUNTEER
  • CONTACT
  • MY PAREXEL PREFERENCE CENTER
  • CLIENT LOGIN
  • LIQUENT®
  • CLINICAL TRIAL INVESTIGATOR
  • SITE MAP
  • TERMS OF SERVICE
  • PRIVACY POLICY
  • EU-U.S. AND SWISS-U.S. PRIVACY SHIELD NOTICE OF CERTIFICATION

Copyright ©2000-2018 PAREXEL International Corporation.